Business
We Are All Sculptra: First-of-its-Kind Galderma Initiative to Demonstrate How Everyone Can Benefit from Sculptra’s Regenerative Properties
ZUG, Switzerland, February 12, 2026--Galderma (SIX: GALD), the pure-play dermatology category leader, today unveiled We Are All Sculptra, a unique program designed to capture the clinical impact of Sculptra® across nine diverse patients – who were all new to injectable aesthetics – over two years.1 This innovative initiative will offer a rare and authentic real-life perspective on the power of regenerative biostimulation to deliver personalized outcomes, and demonstrate how Sculptra adapts to di
About this update from Galderma Group Ag
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":823,"height":209,"url":"https://media.zenfs.com/en/business-wire.com/1fed53970ff2520648cf02bc70e4d3ef"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/Hilg2S8n2wi_AJcG61OFxA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTI0NDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/1fed53970ff2520648cf02bc70e4d3ef","width":823,"height":209},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/qoIYjfZ0WMP11bNKDL1x2g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTE2NDY7aD00MTg7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/1fed53970ff2520648cf02bc70e4d3ef","width":823,"height":209}}},{"type":"list","items":[{"val":[{"type":"text","content":"Galderma unveils We Are All Sculptra, a global campaign capturing the clinical performance of Sculptra® across nine diverse patient profiles and journeys, over two years1","length":170,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Backed by over 25 years of clinical use, Sculptra continues to prove its versatility as a regenerative treatment that works across all three layers of the skin2-6","length":162,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"The campaign captures the patients’ clinical and emotional experiences – including before & after treatment imagery – highlighting Sculptra’s adaptability and reinforcing its role in tailored, science-backed regenerative aesthetic care1","length":240,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":572,"olType":false},{"type":"text","content":"ZUG, Switzerland, February 12, 2026--(BUSINESS WIRE)--Galderma (SIX: GALD), the pure-play dermatology category leader, today unveiled We Are All Sculptra, a unique program designed to capture the clinical impact of Sculptra® across nine diverse patients – who were all new to injectable aesthetics – over two years.1 This innovative initiative will offer a rare and authentic real-life perspective on the power of regenerative biostimulation to deliver personalized outcomes, and demonstrate how Sculptra adapts to different skin types, life stages, and aesthetic goals.1","length":571,"tagName":"p"},{"type":"text","content":"Sculptra is the first proven regenerative biostimulator, backed by over 25 years of clinical use.2-6 With a unique p...